Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

Replace Select Tapered PMC RP 4.3x13mm: medical device reports filed with FDA

2,575 reports name it, 2019–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

2,575
device reports naming the brand
0% of all MAUDE reports · about 377 a year
338
reports, 12 months to August 2026
338 in the 12 months before
1%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 2,575 reports that name the brand "Replace Select Tapered PMC RP 4.3x13mm" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

338 reports arrived in the 12 months to August 2026, close to the 338 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99%) and malfunction (1%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (54.8%), loss of osseointegration (28.4%) and osseointegration problem (10.3%). The patient problems coded most often are failure of implant, pain and numbness. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

04692Sep 2021: 34Oct 2021: 26Nov 2021: 16Dec 2021: 162022Jan 2022: 34Feb 2022: 24Mar 2022: 32Apr 2022: 28May 2022: 36Jun 2022: 24Jul 2022: 38Aug 2022: 34Sep 2022: 30Oct 2022: 24Nov 2022: 32Dec 2022: 522023Jan 2023: 32Feb 2023: 20Mar 2023: 50Apr 2023: 44May 2023: 32Jun 2023: 38Jul 2023: 46Aug 2023: 28Sep 2023: 44Oct 2023: 40Nov 2023: 34Dec 2023: 362024Jan 2024: 30Feb 2024: 34Mar 2024: 14Apr 2024: 16May 2024: 22Jun 2024: 34Jul 2024: 38Aug 2024: 16Sep 2024: 24Oct 2024: 48Nov 2024: 30Dec 2024: 202025Jan 2025: 30Feb 2025: 24Mar 2025: 22Apr 2025: 2May 2025: 0Jun 2025: 0Jul 2025: 92Aug 2025: 46Sep 2025: 32Oct 2025: 46Nov 2025: 24Dec 2025: 202026Jan 2026: 34Feb 2026: 36Mar 2026: 32Apr 2026: 14May 2026: 44Jun 2026: 22Jul 2026: 32Aug 2026: 2

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02224442019: 20820192020: 32720202021: 32820212022: 38820222023: 44420232024: 32620242025: 33820252026: 2162026

Event type and report source

Event type, as classified on the report

Death0%0
Injury99%2,548
Malfunction1%27
Other0%0
Not given0%0

Who filed the report

Manufacturer report52.7%1,358
Voluntary report0%0
User facility report0%0
Distributor report47.3%1,217
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,41254.8%62.8%
Loss of osseointegration73128.4%22.4%
Osseointegration problem26510.3%7.7%
Fracturea broken bone712.8%1.6%
Patient device interaction problem140.5%0.3%
Migrationthe device moved from where it was placed120.5%0.1%
Insufficient device problem information80.3%0.2%
Material deformation80.3%0.1%
Malposition of device60.2%0.1%
Difficult to insertthe device was hard to insert40.2%0.4%
Premature separation40.2%0.1%
Activation, positioning or separation problem20.1%0%
Device markings/labelling problema problem with the device markings or label20.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant2,06580.2%
Painpain, site not specified37214.4%
Numbnessnumbness1345.2%
Inflammationinflammation200.8%
Abscessa collection of pus180.7%
Implant pain180.7%
Appropriate clinical signs, symptoms and conditions term/code not available120.5%
Foreign body in patientpart of a device left in the patient120.5%
Fistula100.4%
Osteomyelitis40.2%
Bone fracture(s)20.1%
Hypersensitivity/allergic reaction20.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureReplace Select Tapered PMC RP 4.3x13mmProduct code DZEAll MAUDE reports
Reports2,5753,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury99%99.2%36.2%
Classified as malfunction1%0.8%62.3%
Filed by the manufacturer52.7%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Replace Select Tapered PMC RP 4.3x13mm reports

How many FDA reports name Replace Select Tapered PMC RP 4.3x13mm?

2,575 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 338 in the latest 12 months.

What kinds of events are reported?

injury (99%) and malfunction (1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (54.8%), loss of osseointegration (28.4%), osseointegration problem (10.3%), fracture (2.8%) and patient device interaction problem (0.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (52.7%) and distributor reports (47.3%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Replace Select Tapered PMC RP 4.3x13mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.